Company Monitoring Page for Novartis

latest headlines for company on cafepharma

With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
Fierce Pharma
Tue, 11/7/17 - 10:55 am
Tags:
Roche, Alecensa, Pfizer, Novartis, lung cancer, Zykadia, Xalkori
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
Tags:
ASH, Bluebird Bio, LentiGlobin, Ziopharm Oncology, Bellicum, BPX-501, Spark Therapeutics, SPK-8011, Biomarin, BMN 270, Juno Therapeutics, CAR-T, Novartis, Geron, imetelstat, Immunogen, IMGN632, IMGN779
Novartis seeks European approval for cell therapy Kymriah
Reuters
Mon, 11/6/17 - 09:25 am
Tags:
Novartis, Europe, CAR-T, Kymriah, diffuse large B-cell lymphoma, acute lymphoblastic leukemia
Novartis and Amgen launch new Alzheimer’s study
Endpoints
Thu, 11/2/17 - 10:12 pm
Tags:
Novartis, Amgen, Alzheimer's disease, CNP520, clinical trials
Juno Therapeutics' 3rd Quarter Boosted by Potential Rival Novartis
Yahoo/Motley Fool
Thu, 11/2/17 - 09:26 am
Tags:
Juno Therapeutics, earnings, Novartis
Novartis Weighs Sale of Dermatology Generics Business
Bloomberg
Wed, 11/1/17 - 09:39 am
Tags:
Novartis, dermatology, M&A
Novartis hustles along another FDA application for CAR-T star, tackling Gilead head on
Endpoints
Tue, 10/31/17 - 09:38 am
Tags:
Novartis, FDA, CAR-T, Kymriah, diffuse large B-cell lymphoma
Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Fierce Pharma
Mon, 10/30/17 - 10:00 am
Tags:
Verzenio, Ibrance, Kisqali, drug launches, breast cancer. Eli Lilly, Pfizer, Novartis
Novartis to buy French cancer specialist AAA for $3.9 billion
Yahoo/Reuters
Mon, 10/30/17 - 09:58 am
Tags:
Novartis, M&A, France, Advanced Accelerator Application, radiopharmaceuticals, oncology
Novartis more and more likely to create a spin-off of Alcon worth $25bn to $35bn
GoinPharma
Thu, 10/26/17 - 10:51 am
Tags:
Novartis, Alcon, spinoffs
What’s driving the rapid growth of the top 20 biopharma companies in the world?
Endpoints
Wed, 10/25/17 - 11:24 am
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, Serono, AbbVie, Sanofi, Amgen, Bayer, GSK
Sandoz raises questions with FDA draft guidance on statistical approaches for biosimilars
Endpoints
Wed, 10/25/17 - 10:59 am
Tags:
Sandoz, Novartis, FDA, biosimilars
Eyes on Alcon as Novartis notches modest growth
Biopharma Dive
Tue, 10/24/17 - 05:31 pm
Tags:
Novartis, earnings, Alcon
Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS
Yahoo/Zacks.com
Mon, 10/23/17 - 09:59 am
Tags:
earnings, Eli Lilly, Biogen, Novartis
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Endpoints
Mon, 10/23/17 - 09:57 am
Tags:
FDA, Novartis, Tafinlar, Mekinist, non-small cell lung cancer
Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod
Fierce Pharma
Thu, 10/19/17 - 09:12 am
Tags:
Gilead Sciences, Kite Pharma, Novartis, CAR-T, FDA, axi-cel, Yescarta, non-Hodgkin's lymphoma, large B-cell lymphoma
Novartis division closing Broomfield operations
Broomfield Enterprise, Colorado
Tue, 10/17/17 - 09:46 am
Tags:
Novartis, drug manufacturing, Sandoz, generics
Corrected: What Q3 earnings will look like for 5 pharma giants
Biopharma Dive
Fri, 10/13/17 - 12:00 pm
Tags:
earnings, JNJ, Roche, Biogen, Eli Lilly, Novartis
No sale for Novartis' $14B Roche stake, but the revamp's not done
Fierce Pharma
Thu, 10/12/17 - 10:11 pm
Tags:
Novartis, Roche
Here Come More Gene Therapies -- And More Pricing Debates
Forbes
Wed, 10/11/17 - 10:03 am
Tags:
gene therapies, drug pricing, Luxturna, Spark Therapeutics, Kymriah, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.